Drug intelligence / Profile preview

Ethanolamine

Development stage
Preclinical
Lead developer
QOL Medical
Modality
Small Molecules
Administration
Oral
01

Overview

Ethanolamine, also known as monoethanolamine (MEA), is a naturally occurring organic chemical compound that contains both a primary amine and a primary alcohol group. It is a fundamental molecular building block for life, serving as a crucial component in the formation of cellular membranes and as a precursor to phosphatidylethanolamine (PE), a major phospholipid. Beyond its common use as a pharmaceutical excipient for buffering or emulsion preparation, Ethanolamine has demonstrated various biological activities. Research indicates its potential to stimulate mammalian cell growth, induce cytoprotective autophagy, and extend lifespan in certain organisms by increasing PE levels, suggesting anti-aging properties. Its metabolism by gut microbiota has also been implicated in inflammatory and metabolic dysregulation. Ethanolamine is currently being investigated in clinical trials as an intervention in tablet form for conditions such as immune thrombocytopenia.

Other names
2-Aminoethan-1-ol2-AminoethanolMonoethanolaminebeta-Aminoethanolbeta-hydroxyethylaminebeta-Aminoethyl alcoholGlycinolOlamineEthylolamine2-HydroxyethylamineColamine

Beyond the preview

Go deeper on Ethanolamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ethanolamine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call